Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Pegylated Liposomal Doxorubicine – Efficacy in Patients with Recurrent High-Grade Glioma

Pegylated Liposomal Doxorubicine – Efficacy in Patients with Recurrent High-Grade Glioma. Cancer. 2004; 15(6):1199-1207.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.